"GHP - Gastroenterology of Southern Indiana is a health care facility that offers a variety of inpatient and outpatient services. It provides treatment solutions for patients with colon cancer, polyps, colitis, diverticulosis, abdominal pain, chronic diarrhea, ulcers, gastric, tumors, rectal bleeding and inflammatory bowel diseases. The center specializes in the areas of esophagogastroduodenoscopy, capsule endoscopy, sigmoidoscopy and abdominal paracentesis. It additionally provides treatment services for various digestive organs, such as esophagus, stomach, liver, pancreas and intestines. The center offers diagnostic, treatment planning, medication administration, liver biopsy and consulting services."

During the past decade, Gastroenterology Health Partners PLLC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastroenterology Health Partners PLLC" #1 sponsor was "Shire" with 3 trials, followed by "Celgene" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Phathom Pharmaceuticals, Inc." with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastroenterology Health Partners PLLC" #1 collaborator was "Novo Nordisk A/S" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Gastroenterology Health Partners PLLC" are "Eosinophilic Esophagitis (EoE)" (3 trials), "Eosinophilic Esophagitis" (2 trials), "Celiac Disease" (1 trials), "Chronic Liver Disease" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Gastroenterology Health Partners PLLC" in a lesser frequency.

Most popular intervention types in "Gastroenterology Health Partners PLLC" are "Drug" (13 trials), "Biological" (2 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "CC-93538" (2 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials) and "JNJ-78934804" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gastroenterology Health Partners PLLC" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Gastroenterology Health Partners PLLC". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Gastroenterology Health Partners PLLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Gastroenterology Health Partners PLLC, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".